Laigo Bio
United Kingdom · $37.6M raised
- Total Funding
- $37.6M
- Last Round
- $6.1M SeedMar 2026
- Rounds
- 4
About
Biotech platform for antibody development
Summary
Laigo Bio is a Biotech company based in United Kingdom. It has raised $37.6M in total across 4 rounds, most recently a $6.1M Seed round in Mar 2026. Investors include Biovance Capital, Kurma Partners and Angelini Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Mar 2026
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...